Tag Archives: Sapacitabine

Cyclacel Reports Phase 2 Survival Data With Sapacitabine in Myelodysplastic Syndromes at 2010 ASH … – Yahoo Finance

BERKELEY HEIGHTS, N.J., Dec. 4, 2010 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (Nasdaq: CYCC – News ) (Nasdaq: CYCCP – News ) (“Cyclacel”) announced today 1-year survival data from a Phase 2 randomized trial of oral sapacitabine capsules, a novel … Continue reading

Share
Posted in Myelodysplastic Syndromes | Tagged , , , , , , , , , , | Leave a comment